TRPM8 and prostate carcinoma: We show that TRPM8 and Rap1 N17 interact in intact prostate cancer cells, validating docking analyses since the point mutation of Y32 in the Rap1 sequence significantly weakened the intracellular interaction with TRPM8 (Figure 5bii).